Comprehensive Neuroscience, Inc

Atlanta, Georgia 30328

0 studies enrolling now · 12 studies all time

What they study most

Bipolar Disorder, Depression, Generalized Anxiety Disorder, Major Depressive Disorder, Obesity, Overweight, Schizoaffective Disorder, Schizophrenia

Studies at this site

• A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode — Completed
• A Twelve Week, Open Label Extension Study in Patients With Schizophrenia — Completed
• A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder — Completed
• Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects — Completed
• PEARL Schizophrenia Maintenance — Completed
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder — Completed
• A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder — Completed
• A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects — Completed
• A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents — Completed
• Major Depressive Disorder With Mixed Features — Withdrawn before enrolling
• Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia — Completed
• ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD — Completed